Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

4.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.0K
Brain Imaging01:14

Brain Imaging

212
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
212

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

How Fluorine-18-labeled Fluorodeoxyglucose PET Changed Clinical Practice in Central Nervous System Disorders.

PET clinics·2026
Same authorSame journal

Future Directions for [18F]FDG PET in Central Nervous System Diseases.

PET clinics·2026
Same authorSame journal

Five Decades of [18F]Fluorodeoxyglucose-PET in Neuropsychiatric Disorders: From Brain Metabolism to Precision Functional Imaging.

PET clinics·2026
Same authorSame journal

Brain [18F]FDG PET in Subjective Cognitive Complaints: From Diagnostic Gap to Neurobiological Insight.

PET clinics·2026
Same author

Brain [18F]FDG PET in Encephalitis and Postinfectious Neurocognitive Syndromes.

PET clinics·2026
Same author

Automatic Extraction of PET RANO Criteria with an Externally Validated Deep Learning Model: Application to [18F]FDOPA PET Imaging.

Neuro-oncology·2026

Related Experiment Video

Updated: Jun 9, 2025

Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level
07:28

Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level

Published on: January 24, 2025

248

Metabolic Brain PET Connectivity.

Tatiana Horowitz1, Matthieu Doyen2, Silvia Paola Caminiti3

  • 1Aix Marseille Univ, Marseille, France; CERIMED, CNRS, Centrale Marseille, Institut Fresnel, Marseille, France; Nuclear Medicine Department, AP-HM, Timone Hospital, Marseille, France.

PET Clinics
|October 31, 2024
PubMed
Summary
This summary is machine-generated.

This review explores how fluorodeoxyglucose-PET metabolic connectivity reveals brain network changes in neurodegenerative diseases like Alzheimer's and Parkinson's. Understanding these brain network alterations is key for diagnosing and treating neurological conditions.

Keywords:
Brain connectivityFDGFluorodeoxyglucoseMetabolic connectivityNeuroimagingPET

More Related Videos

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
09:03

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Published on: October 22, 2019

9.9K
A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat
15:10

A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat

Published on: December 28, 2013

7.0K

Related Experiment Videos

Last Updated: Jun 9, 2025

Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level
07:28

Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level

Published on: January 24, 2025

248
Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
09:03

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Published on: October 22, 2019

9.9K
A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat
15:10

A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat

Published on: December 28, 2013

7.0K

Area of Science:

  • Neuroscience
  • Medical Imaging
  • Neurology

Background:

  • Brain network organization is crucial for cognitive function.
  • Neurodegenerative diseases significantly disrupt brain networks.
  • Metabolic connectivity offers insights into functional brain organization.

Purpose of the Study:

  • To review the role of fluorodeoxyglucose-positron emission tomography (FDG-PET) metabolic connectivity in understanding brain networks.
  • To focus on neurodegenerative diseases, including Alzheimer's, Parkinson's, and frontotemporal dementia.
  • To discuss methodologies and emerging applications of metabolic connectivity analysis.

Main Methods:

  • Review of existing literature on metabolic connectivity using FDG-PET.
  • Analysis of altered connectivity patterns in various neurodegenerative conditions.
  • Exploration of advanced techniques like single-subject analyses.

Main Results:

  • Metabolic connectivity is a valuable tool for assessing brain network organization.
  • Specific patterns of altered metabolic connectivity are observed in Alzheimer's, Parkinson's, and frontotemporal dementia.
  • Emerging applications show promise for personalized diagnostics and understanding brain-body interactions.

Conclusions:

  • FDG-PET based metabolic connectivity is essential for characterizing brain network dysfunction in neurological disorders.
  • Altered connectivity patterns provide biomarkers for neurodegenerative diseases.
  • Future research directions include single-subject analyses and brain-organ interaction studies.